Global /United States /Healthcare /Biotechnology /VXIT

VirExit Technologies, Inc.

VXIT

• OTCMKTS: VXIT • Delayed

0.0018USD 0%

As of 13 June 2026, VirExit Technologies, Inc. has a market cap of $2.85M USD, ranking #46304 globally and #5877 in the United States. It ranks #4105 in the Healthcare sector, and #805 in the Biotechnology industry.

Global Rank

46304

Country Rank

5877

Sector Rank

4105

Industry Rank

805

Key Stats

Market Cap

$2.85MUSD

Net Income (TTM)

-$2.0MUSD

PB Ratio

-2.2

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

James Katzaroff open_in_new

Employees

Founded

2013

Website

virexit.biz open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	5.9%	-5.3%	64%	350%	100%	200%	125%	-95%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	VXIT VirExit Technologies Inc ISIN: US92767Q1022 Shares Out.: Shares Outstanding: 3.564B¹ Shares Float: 3.384B² TV: TradingView: OTC: VXIT SA: Stock Analysis: OTC: VXIT YF: Yahoo Finance: VXIT GF: Google Finance: OTCMKTS: VXIT BA: Barron's: VXIT MS: Morningstar: PINX: VXIT	0.0018 USD	TV: TradingView: OTC: VXIT SA: Stock Analysis: OTC: VXIT YF: Yahoo Finance: VXIT GF: Google Finance: OTCMKTS: VXIT BA: Barron's: VXIT MS: Morningstar: PINX: VXIT

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About VirExit Technologies, Inc.

VirExit Technologies, Inc. develops and provides antiviral technologies, personal protective equipment, and health and wellness products. It offers seated treadmills, nutraceuticals, and boutique style custom candles through its safer place market. The company was formerly known as Poverty Dignified, Inc. VirExit Technologies, Inc. was founded in 2013 and is headquartered in Richland, Washington.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 6M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 6M%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 968K%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 922K%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 878K%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 636K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 2M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 2M%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 1M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 1M%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 986K%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 901K%	-	Germany

chevron_leftBack